Pathogenesis of dengue: challenges to molecular biology - PubMed (original) (raw)
Review
. 1988 Jan 29;239(4839):476-81.
doi: 10.1126/science.3277268.
Affiliations
- PMID: 3277268
- DOI: 10.1126/science.3277268
Review
Pathogenesis of dengue: challenges to molecular biology
S B Halstead. Science. 1988.
Abstract
Dengue viruses occur as four antigenically related but distinct serotypes transmitted to humans by Aedes aegypti mosquitoes. These viruses generally cause a benign syndrome, dengue fever, in the American and African tropics, and a severe syndrome, dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS), in Southeast Asian children. This severe syndrome, which recently has also been identified in children infected with the virus in Puerto Rico, is characterized by increased vascular permeability and abnormal hemostasis. It occurs in infants less than 1 year of age born to dengue-immune mothers and in children 1 year and older who are immune to one serotype of dengue virus and are experiencing infection with a second serotype. Dengue viruses replicate in cells of mononuclear phagocyte lineage, and subneutralizing concentrations of dengue antibody enhance dengue virus infection in these cells. This antibody-dependent enhancement of infection regulates dengue disease in human beings, although disease severity may also be controlled genetically, possibly by permitting and restricting the growth of virus in monocytes. Monoclonal antibodies show heterogeneous distribution of antigenic epitopes on dengue viruses. These epitopes serve to regulate disease: when antibodies to shared antigens partially neutralize heterotypic virus, infection and disease are dampened; enhancing antibodies alone result in heightened disease response. Further knowledge of the structure of dengue genomes should permit rapid advances in understanding the pathogenetic mechanisms of dengue.
Similar articles
- The XXth century dengue pandemic: need for surveillance and research.
Halstead SB. Halstead SB. World Health Stat Q. 1992;45(2-3):292-8. World Health Stat Q. 1992. PMID: 1462664 - Dengue outbreak associated with multiple serotypes--Puerto Rico, 1998.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 1998 Nov 13;47(44):952-6. MMWR Morb Mortal Wkly Rep. 1998. PMID: 9832472 - Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade.
Halstead SB. Halstead SB. Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S830-9. doi: 10.1093/clinids/11.supplement_4.s830. Rev Infect Dis. 1989. PMID: 2665015 Review. - Clinical manifestations of dengue hemorrhagic fever in Puerto Rico, 1990-1991. Puerto Rico Association of Epidemiologists.
Rigau-Pérez JG. Rigau-Pérez JG. Rev Panam Salud Publica. 1997 May;1(5):381-8. doi: 10.1590/s1020-49891997000500007. Rev Panam Salud Publica. 1997. PMID: 9180059 Review. - Dengue in Puerto Rico, 1977: public health response to characterize and control an epidemic of multiple serotypes.
Morens DM, Rigau-Pérez JG, López-Correa RH, Moore CG, Ruiz-Tibén EE, Sather GE, Chiriboga J, Eliason DA, Casta-Velez A, Woodall JP. Morens DM, et al. Am J Trop Med Hyg. 1986 Jan;35(1):197-211. doi: 10.4269/ajtmh.1986.35.197. Am J Trop Med Hyg. 1986. PMID: 3946738
Cited by
- Estimating dynamics of dengue disease in Colombo district of Sri Lanka with environmental impact by quantifying the per-capita vector density.
Chathurangika P, Perera SSN, De Silva SAK. Chathurangika P, et al. Sci Rep. 2024 Oct 20;14(1):24629. doi: 10.1038/s41598-024-76176-5. Sci Rep. 2024. PMID: 39428492 Free PMC article. - A pre-vaccination immune metabolic interplay determines the protective antibody response to a dengue virus vaccine.
Pelletier AN, Sanchez GP, Izmirly A, Watson M, Di Pucchio T, Carvalho KI, Filali-Mouhim A, Paramithiotis E, Timenetsky MDCST, Precioso AR, Kalil J, Diamond MS, Haddad EK, Kallas EG, Sekaly RP. Pelletier AN, et al. Cell Rep. 2024 Jul 23;43(7):114370. doi: 10.1016/j.celrep.2024.114370. Epub 2024 Jun 18. Cell Rep. 2024. PMID: 38900640 Free PMC article. - Dynamics of emergence and genetic diversity of dengue virus in Reunion Island from 2012 to 2022.
Frumence E, Wilkinson DA, Klitting R, Vincent M, Mnemosyme N, Grard G, Traversier N, Li-Pat-Yuen G, Heaugwane D, Souply L, Giry C, Paty MC, Collet L; Local Laboratory Network; Gérardin P, Thouillot F, De Lamballerie X, Jaffar-Bandjee MC. Frumence E, et al. PLoS Negl Trop Dis. 2024 May 20;18(5):e0012184. doi: 10.1371/journal.pntd.0012184. eCollection 2024 May. PLoS Negl Trop Dis. 2024. PMID: 38768248 Free PMC article. - Molecular and Entomological Characterization of 2023 Dengue Outbreak in Dhading District, Central Nepal.
Rimal S, Shrestha S, Paudel SW, Shah Y, Bhandari G, Pandey K, Kharbuja A, Kapandji M, Gautam I, Bhujel R, Takamatsu Y, Bhandari R, Klungthong C, Shrestha SK, Fernandez S, Malavige GN, Pandey BD, Urano T, Morita K, Ngwe Tun MM, Dumre SP. Rimal S, et al. Viruses. 2024 Apr 12;16(4):594. doi: 10.3390/v16040594. Viruses. 2024. PMID: 38675935 Free PMC article. - Approaches of dengue control: vaccine strategies and future aspects.
Akter R, Tasneem F, Das S, Soma MA, Georgakopoulos-Soares I, Juthi RT, Sazed SA. Akter R, et al. Front Immunol. 2024 Feb 29;15:1362780. doi: 10.3389/fimmu.2024.1362780. eCollection 2024. Front Immunol. 2024. PMID: 38487527 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical